Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 235 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2780 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-08 2019-06-24 83504
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-07-03 2019-08-03 88336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-08-30 92026
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-25 2019-11-04 94734
APO-CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-02 2021-07-15 95266
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-16 2019-11-18 96647
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2019-11-27 2020-03-02 99792
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2021-05-03 100281
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2023-07-04 100284
APO-ISMN 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-02-26 2020-03-27 107199
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-04 2020-08-17 116542
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-24 2020-08-17 118766
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-08 2020-07-18 119759
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-08-07 121322
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-06 2020-09-04 121903
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-26 2020-09-02 122994

Showing 121 to 140 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOPERAMIDE 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40823

Showing 41 to 60 of 356